Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)
China
· Delayed Price · Currency is CNY 13.44
+0.11 (0.83%)
May 23, 2025, 3:04 PM CST
SHE:002020 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 704.05 | 711.96 | 618.9 | 662.25 | 612.54 | 653.07 | Upgrade
|
| Depreciation & Amortization | 288.66 | 288.66 | 219.95 | 166.87 | 149.92 | 123.2 | Upgrade
|
| Other Amortization | 22.11 | 22.11 | 11.55 | 33.08 | 32.6 | 31.22 | Upgrade
|
| Loss (Gain) From Sale of Assets | -2.59 | -2.59 | -6.86 | -0.61 | 0.48 | 0.04 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.07 | 0.07 | 0.01 | 0.07 | 8.42 | 0.51 | Upgrade
|
| Loss (Gain) From Sale of Investments | 33.41 | 33.41 | -30.88 | -29.57 | -55.39 | -191.15 | Upgrade
|
| Provision & Write-off of Bad Debts | 13.16 | 13.16 | 6.73 | 3.64 | 10.8 | -1.81 | Upgrade
|
| Other Operating Activities | -156.52 | 26.2 | 15.63 | -1.3 | 22.77 | 19.09 | Upgrade
|
| Change in Accounts Receivable | -249.65 | -249.65 | -93.48 | -250.89 | -208.58 | 34.44 | Upgrade
|
| Change in Inventory | -152.84 | -152.84 | 123.04 | -102.95 | -152.51 | -82.69 | Upgrade
|
| Change in Accounts Payable | 52.3 | 52.3 | -74.58 | 387.41 | -41.84 | -103.68 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | - | - | -0.03 | Upgrade
|
| Operating Cash Flow | 535.53 | 726.16 | 792.84 | 855.78 | 373.46 | 513.21 | Upgrade
|
| Operating Cash Flow Growth | -43.48% | -8.41% | -7.36% | 129.15% | -27.23% | -4.13% | Upgrade
|
| Capital Expenditures | -276.29 | -250.65 | -519.51 | -515.57 | -406.83 | -334 | Upgrade
|
| Sale of Property, Plant & Equipment | 5.26 | 5.2 | 10.27 | 1.99 | 2.93 | 2.44 | Upgrade
|
| Investment in Securities | -1,047 | -1,240 | -260.2 | -342.4 | 508.33 | 707.69 | Upgrade
|
| Other Investing Activities | 55.63 | 47.86 | 31.85 | 118.32 | 37.86 | 87.8 | Upgrade
|
| Investing Cash Flow | -1,263 | -1,438 | -737.59 | -737.66 | 142.29 | 463.93 | Upgrade
|
| Long-Term Debt Issued | - | 738.29 | 585 | 236.54 | 146.16 | 297.6 | Upgrade
|
| Total Debt Issued | 627.94 | 738.29 | 585 | 236.54 | 146.16 | 297.6 | Upgrade
|
| Long-Term Debt Repaid | - | -742 | -550 | -166.05 | -320.64 | -358.76 | Upgrade
|
| Total Debt Repaid | -774 | -742 | -550 | -166.05 | -320.64 | -358.76 | Upgrade
|
| Net Debt Issued (Repaid) | -146.06 | -3.71 | 35 | 70.49 | -174.48 | -61.15 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 515.56 | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | - | -200.99 | Upgrade
|
| Common Dividends Paid | -258.31 | -258.31 | -258.31 | -258.56 | -232.17 | -235.42 | Upgrade
|
| Other Financing Activities | -463.41 | -18.14 | -22.3 | 0.04 | 4.47 | 0.18 | Upgrade
|
| Financing Cash Flow | -867.78 | -280.16 | -245.61 | -188.03 | 113.38 | -497.38 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1.66 | 2.99 | 2.71 | 14.87 | -3.75 | -9.95 | Upgrade
|
| Net Cash Flow | -1,593 | -988.87 | -187.65 | -55.05 | 625.38 | 469.81 | Upgrade
|
| Free Cash Flow | 259.23 | 475.52 | 273.32 | 340.2 | -33.37 | 179.21 | Upgrade
|
| Free Cash Flow Growth | -57.34% | 73.98% | -19.66% | - | - | -9.47% | Upgrade
|
| Free Cash Flow Margin | 6.40% | 11.43% | 6.83% | 9.00% | -0.96% | 5.50% | Upgrade
|
| Free Cash Flow Per Share | 0.31 | 0.55 | 0.32 | 0.40 | -0.04 | 0.23 | Upgrade
|
| Cash Income Tax Paid | 251.65 | 260.88 | 245.5 | 262.09 | 231.14 | 246.5 | Upgrade
|
| Levered Free Cash Flow | -279.19 | 539.05 | -85.08 | 312.3 | -204.19 | -31.16 | Upgrade
|
| Unlevered Free Cash Flow | -275.61 | 543.89 | -80.51 | 316.06 | -201.08 | -27.41 | Upgrade
|
| Change in Net Working Capital | 732.97 | -37.17 | 154.42 | -248.06 | 337.9 | 172.4 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.